D
Sell
3/11/2016Downgrade
Axxess Pharma, Inc. (AXXED) was downgraded to D from C on 3/11/2016 due to a substantial decline in the volatility index, valuation index and total return index.
C
Hold
11/30/2015Upgraded
Axxess Pharma, Inc. (AXXE) was upgraded to C from C- on 11/30/2015 due to a substantial increase in the valuation index.
C
Hold
11/13/2015Downgrade
Axxess Pharma, Inc. (AXXE) was downgraded to C- from C on 11/13/2015 due to a decline in the total return index and volatility index.
C
Hold
10/7/2015Upgraded
Axxess Pharma, Inc. (AXXE) was upgraded to C from C- on 10/7/2015 due to an increase in the growth index, efficiency index and valuation index. Earnings per share increased from $0.005 to $0.03, net income increased 350.6% from $949.6 to $4.28M, and EBIT increased 6.97% from -$386.2 to -$413.1.
C
Hold
2/27/2015Upgraded
Axxess Pharma, Inc. (AXXE) was upgraded to C- from on 2/27/2015 due to a significant increase in the efficiency index, solvency index and volatility index. The quick ratio increased from 0.01 to 0.11.
